Literature DB >> 7946750

Myocardial phenotype changes in heart failure: cellular and subcellular adaptations and their functional significance.

G Hasenfuss1, H Just.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7946750      PMCID： PMC1025567          DOI： 10.1136/hrt.72.2_suppl.s10

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  72 in total

1.  Improvement of cholera toxin-catalyzed ADP-ribosylation by endogenous ADP-ribosylation factor from bovine brain provides evidence for an unchanged amount of Gs alpha in failing human myocardium.

Authors:  P Schnabel; M Böhm; P Gierschik; K H Jakobs; E Erdmann
Journal:  J Mol Cell Cardiol       Date:  1990-01       Impact factor: 5.000

2.  Stretching cardiac myocytes stimulates protooncogene expression.

Authors:  I Komuro; T Kaida; Y Shibazaki; M Kurabayashi; Y Katoh; E Hoh; F Takaku; Y Yazaki
Journal:  J Biol Chem       Date:  1990-03-05       Impact factor: 5.157

3.  Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes.

Authors:  T G Parker; S E Packer; M D Schneider
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

Review 4.  To what extent do congestive heart failure patients in sinus rhythm benefit from digoxin therapy? A systematic overview and meta-analysis.

Authors:  R Jaeschke; A D Oxman; G H Guyatt
Journal:  Am J Med       Date:  1990-03       Impact factor: 4.965

5.  Calcium antagonist binding sites in failing and nonfailing human ventricular myocardium.

Authors:  R P Rasmussen; W Minobe; M R Bristow
Journal:  Biochem Pharmacol       Date:  1990-02-15       Impact factor: 5.858

6.  Antibodies to ADP-ATP carrier--an autoantigen in myocarditis and dilated cardiomyopathy--impair cardiac function.

Authors:  K Schulze; B F Becker; R Schauer; H P Schultheiss
Journal:  Circulation       Date:  1990-03       Impact factor: 29.690

7.  Altered sarcoplasmic reticulum Ca2(+)-ATPase gene expression in the human ventricle during end-stage heart failure.

Authors:  J J Mercadier; A M Lompré; P Duc; K R Boheler; J B Fraysse; C Wisnewsky; P D Allen; M Komajda; K Schwartz
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

8.  Increase of Gi alpha in human hearts with dilated but not ischemic cardiomyopathy.

Authors:  M Böhm; P Gierschik; K H Jakobs; B Pieske; P Schnabel; M Ungerer; E Erdmann
Journal:  Circulation       Date:  1990-10       Impact factor: 29.690

9.  Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group.

Authors:  B F Uretsky; M Jessup; M A Konstam; G W Dec; C V Leier; J Benotti; S Murali; H C Herrmann; J A Sandberg
Journal:  Circulation       Date:  1990-09       Impact factor: 29.690

10.  Role of intracellular calcium handling in force-interval relationships of human ventricular myocardium.

Authors:  J K Gwathmey; M T Slawsky; R J Hajjar; G M Briggs; J P Morgan
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808
View more
  1 in total

1.  The Loss of GSTM1 Associates with Kidney Failure and Heart Failure.

Authors:  Adrienne Tin; Robert Scharpf; Michelle M Estrella; Bing Yu; Megan L Grove; Patricia P Chang; Kunihiro Matsushita; Anna Köttgen; Dan E Arking; Eric Boerwinkle; Thu H Le; Josef Coresh; Morgan E Grams
Journal:  J Am Soc Nephrol       Date:  2017-07-18       Impact factor: 10.121
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.